Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil.

Source:http://linkedlifedata.com/resource/pubmed/id/19302565

Download in:

View as

General Info

PMID
19302565